Stanford Neurogenetics and Neurogenomics Team

Rebecca Levy, MD, PhD
Instructor

Dr. Rebecca Levy studied neurobiology at Yale University and then neuroscience of schizophrenia and neurometabolic disorders during her M.D. and Ph.D. at Columbia University. She transitioned to Stanford University for clinical training in Child Neurology residency followed by Medical Genetics fellowship in order to become a neurogeneticist. Her research includes use of human-induced pluripotent stem cell-derived neural organoids to model early neurodevelopment, as well as clinical projects on phenotypes of rare neurogenetic disorders. Her goal is to diagnose individuals in her clinic, study the underlying pathways of the disorders in her lab, and translate that research into novel treatment approaches.

Jacinda Sampson, MD, PhD
Clinical Professor

Dr. Jacinda Sampson received her MD and a PhD in biochemistry from University of Alabama at Birmingham, and completed her neurology residency and neurogenetics fellowship at the University of Utah. She served at Columbia University Medical Center prior to joining Stanford University Medical Center in 2015. Her areas of interest include myotonic dystrophies, Duchenne muscular dystrophy, and neurogenetic disorders such as neurofibromatosis, hereditary spastic paraparesis, spinocerebellar ataxia, among others. She is interested in clinical trials for treatment of neurogenetic disorders, and in the clinical application of next-generation genomic sequencing to genetic testing.

Safwan Jaradeh, MD
Professor, Neurology & Neurological Sciences
Director, Autonomic Disorders Program

Dr. Jaradeh's clinical interests include autonomic disorders, small fiber neuropathies and the development of effective methods of testing and treating these disorders. Prior work has focused on small fiber, painful and autonomic neuropathies; syncope and syndromes of orthostatic intolerance including postural orthostatic tachycardia (POTS); gastrointestinal motility dysfunction; cyclic vomiting; neurology of gastroesophageal reflux; non-allergic rhinitis syndromes; and the relationship between the autonomic nervous system and normal or abnormal sleep. Additional areas of interest include the neurology of phonation and swallowing disorders, autoimmune neuromuscular disorders, hereditary neuropathies, and peripheral nerve injury and repair.

Dr. Jaradeh is board certified in Neurology and in Clinical Neurophysiology by the American Board of Psychiatry and Neurology. He is also board certified in Electrodiagnostic Medicine by the American Association of Neuromuscular & Electrodiagnostic Medicine, and board certified in Autonomic Disorders by the UCNS Board of the American Autonomic Society.

Prior to his arrival at Stanford Hospital and Clinics, Dr. Jaradeh was the Chair and a Professor at Medical College of Wisconsin from 2000 to 2011.

Dr. Jaradeh is passionate about teaching. He won several teaching awards in Wisconsin, and more recently won the L. Forno Award for Teaching Excellence in the Neurology Department in 2013. He was also nominated by Stanford medical students in 2013 for the Neurology Clerkship Award. He has also been included in Top Doctors list for more than a decade.

Kevin Graber, MD
Clinical Professor, Neurology & Neurological Sciences
Director of Outpatient Epilepsy Clinic

Dr. Kevin Graber earned his MD from Indiana University in 1992 and completed his training in Neurology & Neurological Sciences at Stanford Medical Center. Dr Graber has earned prestigious research awards and has served on several national committees including the American Epilepsy Society, CURE, and Epilepsy Foundation. As a Clinician Educator, Dr. Graber provides clinical care to patients with epilepsy, and teaches fellows, residents, and medical students. Dr. Graber's research is focused on discovering how brain injuries, such as trauma, lead to epilepsy.

Scheherazade Le, MD
Clinical Professor, Neurology & Neurological Sciences

Dr. Le's clinical research is focused on waveform analysis of motor evoked potentials and the prevention of spinal motor deficits in the intraoperative setting. She is also interested in developing techniques to obtain motor evoked potentials under partial paralysis in the endovascular suite. She is involved with trainee education and has clinical interests in epilepsy, electroencephalography and general neurology.

Yi Li, MD, PhD
Clinical Associate Professor, Neurology & Neurological Sciences

Dr. Yi Li received her M.D. and Ph.D. in neurology and neuroscience from Central South University in China. She completed her residency training from University of Massachusetts Medical School, during which time she received a Safety and Quality Award from the American Academy of Neurology. She then continued her training as an epilepsy clinical and research fellow at Stanford. She is also a graduate of the Stanford Genetics and Genomics Certificate Program which develops skills in the field of genetics, genomics, and personalized medicine. She joined the faculty at Stanford in 2020, and has been interested in finding biomarkers to help epilepsy patients to identify disease risks as well as personalized treatment. Her area of interest includes medically refractory epilepsy management, precision medicine and genetics in epilepsy, epilepsy clinical research, and improving quality of patient care.  

Brenda E. Porter, MD, PhD
Professor, Neurology & Neurological Sciences

Dr. Brenda Porter is Professor of Neurology at Stanford University. She received her M.D. and Ph.D. from Washington University in St. Louis. She traveled east to complete her child neurology fellowship at the Children’s Hospital of Philadelphia. She went on to complete a combined clinical and research fellowship in epilepsy. Dr. Porter developed an interest in difficult to treat epilepsy, with a special focus on children with neuronal developmental disorders leading to epilepsy such as tuberous sclerosis and focal cortical dysplasia. Her clinical research focuses on improving outcomes in epilepsy surgery by better defining the epileptic network using a variety of intracranial EEG features. She enjoys working in her lab studying the molecular and cellular changes that contribute to the development of epilepsy. Her research has shown that suppression of CREB a transcription factor can decrease the severity of epilepsy and is hoping to expand on this finding and someday turn her research findings into a therapeutic strategy for preventing epilepsy.

She enjoys teaching students in small groups or one-on-one in the clinic. An especially enjoyable afternoon is a lively discussion while reading EEGs with the epilepsy fellows. She is director of the Stanford Tuberous Sclerosis Clinic and medical director of the EEG lab at Lucile Packard. Currently she sits on the NIH Neuroscience Training (NST-1) study section and has helped CURE and the Tuberous Sclerosis Alliance with their grant reviews. Active in the American Epilepsy Society and the Child Neurology Society, she has served on numerous committees over the years.

Natalia Gomez-Ospina
Assistant Professor, Pediatrics (Genetics & Stem Cell Transplantation)

Dr. Gomez-Ospina was born and raised in Medellin, Colombia. She began her undergraduate studies in petroleum engineering at the Universidad Nacional de Colombia before moving to Colorado. She double majored at the University of Colorado Boulder, completing her bachelor’s degree in Molecular Cellular and Developmental Biology as well as Biochemistry. She graduated summa cum laude and wrote an honors thesis entitled “Role of the quiescent center in the regeneration of the root cap in Zea Mays.” She then completed her combined MD, PhD at Stanford Medical School, where her PhD work focused on understanding the novel functions of voltage-gated calcium channels. Her PhD thesis, “The calcium channel CACNA1C gene: multiple proteins, diverse functions,” was published in Cell. After completion of her dual degrees, she did her preliminary year in internal medicine at Santa Barbara Cottage hospital before starting residency in Dermatology at Johns Hopkins Hospital. She completed residency in Medical Genetics at Stanford Hospital and clinics.

Her post-doctoral research was with Dr. Matthew Porteus in Pediatric Stem Cell transplantation, where she began to develop genome editing-based strategies in stem cells as a therapies for metabolic diseases. She is currently an instructor in the Department of Pediatrics. For her clinical practice she sees patients with suspected genetic disorders, and is also in charge of the enzyme replacement service for lysosomal storage disorders at Lucile Packard Children’s hospital. She has been the lead author in research studies in The New England Journal of Medicine, Cell, Nature Communications, and American Journal of Medical Genetics.

Richard J. Reimer, MD
Professor, Neurology & Neurological Sciences

Dr. Richard Reimer received his MD from Emory University and completed his neurology residency and fellowship in molecular biology with Robert Edwards at the University of California San Francisco before joining Stanford University in 2001. His areas of interest include lysosomal storage disorders such as Gaucher disease, Fabry disease, and sialic acid storage disorders among others. He is interested in the connection between lysosomal dysfunction and neurodegeneration and development of novel treatment of lysosomal storage disorders.

Ami Shah
Clinical Professor, Pediatrics - Stem Cell Transplantation

I did my training in Pediatrics and Hematology/ Oncology at Childrens Hospital Los Angeles where I was an attending physician for 15 years. I joined Stanford University in 2015 as a clinical attending in the Division of Stem Cell Transplantation and Regenerative Medicine. My areas of clinical expertise have been in the areas of transplantation for immune deficiencies and immune reconstitution post HSCT. I was involved with several clinical gene therapy trial for SCID and ALD. My other main areas of research have been in the neurocognitive function post HSCT. I have been involved with several national committees addressing the late effects of HSCT within the ASBMT and COG.

Gregory Enns, MD
Professor, Pediatrics - Genetics

Zihuai He, PhD
Associate Professor, Neurology and Neurological Sciences (Neurology Research), Medicine (Computational Medicine) and, by courtesy, Biomedical Data Science

Dr. He received his PhD from the University of Michigan in 2016. Following a postdoctoral training in biostatistics at Columbia University, he joined Stanford University as an assistant professor of neurology and of medicine in 2018. His research is concentrated in the area of statistical genetics and integrative analysis of omics data, attempting to develop new statistical methodologies that aid with the identification and interpretation of complex biological pathways involved in human diseases, particularly neurological disorders. His methodology interest includes high-dimensional data analysis, correlated (longitudinal, familial) data analysis and machine learning algorithms.

Sharon Sha, MD, MS
Clinical Professor, Neurology & Neurological Sciences

Dr. Sha received her Bachelor’s degrees in Cognitive Science and Molecular Cell Biology emphasizing in Neurobiology from UC Berkeley. She went on to obtain a Master’s degree in Physiology and MD from Georgetown University. She trained in Neurology at UCLA and Stanford University and completed a clinical and research fellowship in behavioral neurology at UCSF where she focused on identifying biomarkers for genetic forms of frontotemporal dementia and caring for patients with movement disorders and cognitive impairment.

Dr. Sha’s clinical expertise include Alzheimer’s disease, frontotemporal dementia, Lewy Body disease, corticobasal syndrome, progressive supranuclear palsy, Huntington’s disease, ataxia, multiple system atrophy, and other dementias. She is currently director of the Huntington’s disease and Ataxia clinic.

Dr. Sha’s non-clinical time is spent conducting clinical trials as the Director of the Memory Disorders Clinical Trials Program in order to identify disease modifying treatments for dementia. She has a special interest in genetic forms of dementia and the cognitive impairment in parkinsonian-related disorders. She is also director of the Stanford Behavioral Neurology Clinical Fellowship.

Sharon Sha, MD, MS
Clinical Professor, Neurology & Neurological Sciences

Dr. Sha received her Bachelor’s degrees in Cognitive Science and Molecular Cell Biology emphasizing in Neurobiology from UC Berkeley. She went on to obtain a Master’s degree in Physiology and MD from Georgetown University. She trained in Neurology at UCLA and Stanford University and completed a clinical and research fellowship in behavioral neurology at UCSF where she focused on identifying biomarkers for genetic forms of frontotemporal dementia and caring for patients with movement disorders and cognitive impairment.

Dr. Sha’s clinical expertise include Alzheimer’s disease, frontotemporal dementia, Lewy Body disease, corticobasal syndrome, progressive supranuclear palsy, Huntington’s disease, ataxia, multiple system atrophy, and other dementias. She is currently director of the Huntington’s disease and Ataxia clinic.

Dr. Sha’s non-clinical time is spent conducting clinical trials as the Director of the Memory Disorders Clinical Trials Program in order to identify disease modifying treatments for dementia. She has a special interest in genetic forms of dementia and the cognitive impairment in parkinsonian-related disorders. She is also director of the Stanford Behavioral Neurology Clinical Fellowship.

Keith P. Van Haren, MD
Associate Professor, Neurology & Neurological Sciences (Pediatric Neurology) and of Pediatricss

Dr. Keith Van Haren is an Associate Professor of Neurology at Stanford University. He spent most of his life in Catholic schools, eventually receiving his B.A. in Chemistry at the College of the Holy Cross. Following graduation, he spent a year in the Jesuit Volunteer Corps enlisted as a mental health case manager in western Montana. Dr. Van Haren originally intended to save the world as a primary care doctor when he enrolled for his M.D. at the University of Rochester, but stumbled upon oligodendrocytes and neurology during a medical student research fellowship. Since that time, he has focused his efforts on saving myelin, a more feasible and still very interesting task.

Dr. Van Haren completed his pediatrics residency at Massachusetts General Hospital and his neurology training at Stanford. He now runs two multidisciplinary clinics at LPCH. In the White Matter Clinic, he and Dr. Gregory Enns, Associate Professor of Genetics & Metabolism, see patients from around the country with a wide range of genetic disorders of myelin (e.g., X-linked adrenoleukodystrophy). In the Neuroinflammation Clinic, he and Dr. Jennifer Frankovich, Assistant Professor of Rheumatology, treat children with a wide range of inflammatory disorders of the nervous system (e.g., multiple sclerosis).

Dr. Van Haren completed his post-doctoral work in the Stanford laboratories of Larry Steinman and Bill Robinson, where he studied the role autoantibodies in neuroinflammation. His current laboratory work is focused on the role of monocytes and microglia in X-linked adrenoleukodystrophy and multiple sclerosis while his clinical research is focused on developing preventive strategies to reduce serious medical complications among leukodystrophy patients. He recently helped found the first leukodystrophy consortium in North America. His research has been supported by grants from the Lucile Packard Foundation for Children’s Health, the Child Neurology Foundation, and the National Institutes of Health.

John W. Day, MD, PhD
Professor, Neurology & Neurological Sciences
Director, Stanford Division of Neuromuscular Medicine

Dr. Day has over 25 years of experience in diagnosing, treating and supporting patients with neuromuscular diseases.  He is involved in ongoing research defining causes, diagnosis and novel treatments of genetic neuromuscular disorders.  Prior to his arrival at Stanford in 2011, Dr. Day directed the Paul and Sheila Wellstone Muscular Dystrophy Center at University of Minnesota.  Dr. Day graduated from the Albert Einstein College of Medicine and completed his Residency and Fellowship at University of California Medical School in San Francisco.  Dr. Day is Board Certified in Neurology by the American Board of Psychiatry and Neurology.

Dr. Day serves as an advisor to many scientific committees researching neuromuscular diseases, including NIH’s Advisory Committees on Muscular Dystrophy and Muscular Dystrophy research.

His areas of interest include most areas of nerve and muscle diseases, in particular, muscular dystrophies, motor neuron diseases, Ataxia and Myasthenia Gravis.

Maxwell Greene, MD
Clinical Assistant Professor, Neurology & Neurological Sciences

Director, Stanford Division of Neuromuscular MedicineDr. Greene received his medical degree from Thomas Jefferson University in Philadelphia, where he was inducted into the Gold Humanism Honor Society, and was the recipient of the American Academy of Neurology medical student prize for excellence in Neurology. He then went on to complete neurology residency at the University of Pennsylvania, where he was the recipient of an R25 grant from the NIH, and won the Samuel T. Zeritsky award for research at Penn. He then completed fellowship in EMG and Neuromuscular Medicine and a research fellowship at the University of Pennsylvania.

Dr. Greene is board-certified in Neurology and Neuromuscular Medicine by the American Board of Psychiatry and Neurology. He was an Assistant Professor at the University of California, San Francisco, from 2017 before joining Stanford in 2020.  His interests and research include acquired and inherited neuromuscular diseases, including nerve disorders such as Charcot Marie Tooth (CMT) and Amyotrophic Lateral Sclerosis (ALS), and muscle disorders such as Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy (FSH, FSHD).  

Jenna Klotz, MD, MS
Clinical Associate Professor, Neurology & Neurological Sciences

Dr. Jenna Klotz is Clinical Associate Professor of Neurology at Stanford University.  She received a B.S. in physics and French literature from the College of William and Mary.  She later completed her M.S. in physiology at University of Cincinnati, where she also earned her M.D. She then completed residencies in pediatrics and child neurology at Stanford.  In her last year she was chief resident and lauded for her teaching.  Subsequently Dr. Klotz completed a clinical neurophysiology fellowship at Stanford with a focus on neuromuscular medicine.  She joined the Stanford faculty in 2018.  Currently, she sees a variety of patients in general child neurology clinic and also works as part of the multidisciplinary pediatric neuromuscular team.  She also performs pediatric EMG/nerve conduction studies.

Jenna lives in Redwood City with her husband, Arek, and their son, Arthur. She likes to spend her weekends taking exercise classes followed immediately by brunch and playing cooperative board games.  She loves taking her son Arthur to swimming class and the park.

Carly Siskind, MS, LCGC
Clinical Associate Professor (Affiliated), Neurology & Neurological Sciences
Senior Genetic Counselor

Before joining the neuromuscular team in 2011, Carly Siskind worked in neurogenetics at Wayne State University in Detroit. She sees patients both at Stanford Hospital and Clinics and Lucile Packard Children’s Hospital. Ms. Siskind is a Clinical Assistant Professor of Neurology (Affiliated), with her main research focus being Charcot-Marie-Tooth disease.

Ms. Siskind obtained her Bachelor’s degree from the University of Michigan with a major in Biology, minor in Global Change and a teaching certificate for high school science. She obtained her Master’s degree from Northwestern University in Chicago. She was board certified by the National Society of Genetic Counselors in 2009 and licensed by the state of California in 2011.

Carolina Tesi Rocha, MD
Clinical Professor, Neurology & Neurological Sciences, and by courtesy, Pediatrics

Dr. Carolina Tesi Rocha is a Clinical Professor in Neurology at Stanford University. She received her B.A and M.D. from University of Buenos Aires, Argentina, where she completed her residency in pediatrics and neurology. In 2001, she moved to the United States to complete an international fellowship in neuromuscular disorders, involving basic and clinical research at Children’s National Medical Center in Washington, DC. After five years of working actively in the neuromuscular field, she decided to become board certified in the US and completed her internship in pediatrics at Georgetown University Hospital and a child neurology fellowship at Children’s National Medical Center. After that fellowship, Dr. Tesi Rocha was awarded a K12 Neurological Sciences Academic Development Award through the NINDS at NIH. She became the director of the neuromuscular program at Children’s. In 2013 she was recruited to Stanford University to join the expanding neuromuscular division.

Dr. Tesi Rocha’s major research interest is to develop novel treatments for neuromuscular disorders including muscular dystrophy, spinal muscular atrophy and congenital myopathies. She is an active member of the American Academy of Neurology, Child Neurology Society, World Muscle Society, and the American Association of Neuromuscular and Electrodiagnostic Medicine.

Lawrence Recht, MD
Professor of Neurology and Neurological Sciences, and by courtesy, Neurosurgery
Director, Adult Neuro-Oncology

Dr. Lawrence Recht received his medical degree from Columbia University College of Physicians and Surgeons in New York City. He completed his training as a Resident in Neurology at Columbia Presbyterian, Neurological Institute of New York. His interest in helping people with brain tumors led him to additional training and completion of a Fellowship in Neuro-Oncology at Memorial Sloan Kettering Cancer Institute in New York.

As an attending in Neurology with a specialty in Neuro-Oncology, Dr. Recht moved to the University of Massachusetts Medical School where he spent 19 years caring for patients and working in his research lab to try to find a cure for brain tumor. During this time Dr. Recht became convinced that it was better for patients to find out how and why a brain tumor evolved so that it could be treated earlier rather than directing his efforts toward treating the tumor after it had already caused disability.

In 2004, Dr Recht relocated to Stanford to work on furthering his research on Early Detection of Brain Tumor and to develop an expanded Adult Neuro-Oncology Program. Belief in hope and quality of life drives Dr. Recht and his team's practice of caring for patients and families with brain tumor and neurologic complications of cancer. Clinical studies are also provided and available for patients with specific conditions who are interested in adding experimental treatments to their care.

Efforts in Dr. Recht's research laboratory are directed towards applying early detection strategies to the treatment of brain tumors. In addition, other work in his laboratory is directed at reversing the damaging side effects of treatment-related brain injury.

Sarada Sakamuri, MD
Clinical Associate Professor, Neurology & Neurological Sciences, and by courtesy, Neurosurgery 

Dr. Sakamuri received her medical degree from New Jersey Medical School in Newark, NJ, where she focused on community health education and was elected a member of the Alpha Omega Alpha Honor Society.  She completed her neurology residency at Stanford University and served as chief resident.  She pursued her passion for neuromuscular disorders by completing fellowships in EMG/Clinical Neurophysiology and Neuromuscular Medicine at Stanford, and a concurrent research fellowship at Forbes Norris MDA/ALS Research Center.

Dr. Sakamuri is board-certified in Neurology and in Neuromuscular disorders by the American Board of Psychiatry and Neurology.  Her interests and research include respiratory dysfunction in neuromuscular disease, Lambert Eaton myasthenic syndrome, nemaline myopathies, and myotonic dystrophy.  

Dr. Sakamuri also enjoys medical education.  She is the Associate Director of the Neuromuscular Medicine Fellowship.  She previously served as a teaching fellow for medical students at Stanford School of Medicine, and as a clinical instructor at Jagiellonian University Medical College in Poland.

Cynthia J. Campen, MD, MS
Clinical Professor, Neurology & Neurological Sciences, and by courtesy, Neurosurgery & Pediatrics

Dr. Cynthia Campen is a Clinical Professor in Neurology at Stanford University. She received her B.S. from University of California, Davis, and her M.D. from University of California, San Francisco, where she completed her residency in pediatrics. She then left the Bay Area briefly for her child neurology residency at the Children's Hospital of Philadelphia. She returned to California for her fellowship in pediatric neuro-oncology at Lucile Packard Children’s Hospital, during which she also completed a master’s degree in epidemiology. Dr. Campen now attends in child neurology and pediatric neuro-oncology and has a clinical interest in neurofibromatosis type I. She is also the Program Director for Child Neurology Residency.

Dr. Campen’s research interests include epidemiology of childhood brain tumors, late effects of brain tumor treatments, intracranial vasculopathy, and neurofibromatosis. She is an active member  of the American Academy of Neurology, Child Neurology Society, American Society of Clinical Oncology, Children’s Oncology Group, and Society for Neuro-Oncology.

Steven Chang, MD
Professor, Neurosurgery, and by courtesy, Otolaryngology, Head & Neck Surgery (OHNS) & Neurology & Neurological Sciences
Director, Neurogentic Oncology Program

Dr. Steven Chang received his medical degree from Stanford University. He completed his neurosurgical training at Stanford with a focus on stereotactic radiosurgery, cerebrovascular disease, and brain and spinal tumors. He is recognized as an expert in Cyberknife radiosurgery and surgical resection of brain tumors. Dr. Chang is a research interest in neurogenetics and proteomics.

Jaimie M. Henderson, MD
Professor, Neurosurgery, and by courtesy Neurology & Neurological Sciences
Director, Stereotactic and Functional Neurosurgery

Dr. Henderson has directed the Stereotactic and Functional Neurosurgery program at Stanford since 2004. He is an internationally recognized expert in neuromodulation (the use of implantable devices such as deep brain stimulators and other neurostimulation devices) to treat neurological disorders. He was an investigator in the first multi-center trial of deep brain stimulation (DBS) in the United States from 1996-1999, and has continued to pioneer this therapy over the past two decades, participating in studies of DBS for a number of disorders including  epilepsy and depression. From 2007-2009, Dr. Henderson was elected to serve as President of the North American Neuromodulation Society, guiding policy and promoting awareness of this new and rapidly growing field.

Throughout his career, Dr. Henderson has been intimately involved in the development of the field of image-guided surgery, which has revolutionized the practice of neurosurgery, allowing for safer and more effective operations with reduced operating time. His groundbreaking work on  frameless functional neurosurgery has become the standard technique for many neurosurgeons throughout the world. His areas of clinical interest include the treatment of movement disorders, epilepsy and pain, leveraging the innovations he has helped develop in image-guided surgery and neuromodulation

Dr. Henderson's current research focuses on the development of new neural interfacing techniques and the fundamental understanding of their mechanisms of action. He co-directs the Stanford Neural Prosthetics Translational Laboratory with Krishna Shenoy, Ph.D., (Departments of Neuroscience and Electrical Engineering), developing brain-computer interface systems and the investigating how the human brain controls movement. He is currently directing a clinical trial investigating the use of DBS to improve attention and concentration for people who have suffered moderate-to-severe traumatic brain injury.

Thomas J. Wilson, MD
Clinical Professor, Neurosurgery, and by courtesy, Neurology & Neurological Sciences

Dr. Thomas J. Wilson was born in Omaha, Nebraska.  He attended the University of Nebraska College of Medicine, earning his MD with highest distinction.  While a medical student, he was awarded a Howard Hughes Medical Institute Research Training Fellowship and spent a year in the lab of Dr. Rakesh Singh at the University of Nebraska.  He completed his residency training in neurological surgery at the University of Michigan and was mentored by Dr. Lynda Yang and Dr. John McGillicuddy in peripheral nerve surgery.  Following his residency, he completed a fellowship in peripheral nerve surgery at the Mayo Clinic in Rochester, Minnesota, working with Dr. Robert Spinner.  He is now Clinical Assistant Professor and Co-Director of the Center for Peripheral Nerve Surgery at Stanford University.  He is also currently endeavoring to earn a Master of Public Health (MPH) degree from the prestigious Bloomberg School of Public Health at Johns Hopkins University. His research interests include peripheral nerve outcomes research using large data sets and multi-institutional registries, clinical trials advancing options for patients with peripheral nerve pathologies, and translational research focused on deriving methods for data-driven intraoperative decision making using intraoperative electrophysiology, advanced imaging techniques, and genetic expression information.  His wife, Dr. Monique Wilson, is a practicing dermatologist in the Bay Area. 

Neil Schwartz, MD, PhD
Clinical Professor, Neurology & Neurological Sciences, and by courtesy, Neurosurgery

Dr. Schwartz joined the Stanford Stroke Center in 2004 as a Fellow in Vascular Neurology and has remained on as Faculty since 2007. Currently, his primary focus is the care of patients with cerebrovascular disease in both the inpatient and outpatient setting. He has expertise in caring for patient with both ischemic and hemorrhagic strokes. He has a particular interest and expertise in cervical artery dissection and non-atherosclerotic vasculopathies, and serves as the Director of the new Young Stroke Program at Stanford. Dr Schwartz is a national leader in neurological education and is the Associate Program Director for the Stanford Neurology Residency Program and is the Medical Director of inpatient Neurology and Neurosurgery wards for Stanford Health Care.

Sarah Lee, MD
Clinical Associate Professor, Neurology & Neurological Sciences

Dr. Sarah Lee is Clinical Associate Professor in Neurology at Stanford University.  She received a B.A. in comparative literature from Columbia University and worked at The Paris Review and Random House before returning to Columbia to complete the post-baccalaureate premedical program in 2003.  She received her M.D. from Albert Einstein College of Medicine, where she graduated with special distinction in neurology, and went on to complete her child neurology residency at Stanford, followed by a neurovascular fellowship at the Stanford Stroke Center.  She attends on both the child neurology service as well as the adult stroke service.  Her main clinical and research focus involves optimizing diagnosis, treatment, and rehabilitation for pediatric and young adult stroke patients.  Additional areas of particular interest include venous sinus thrombosis, inflammatory and non-inflammatory vasculopathies, stroke in pregnancy, and aphasia.